SEC Form 4 · accession 0001225208-16-028106
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Annette F Favorite
Officer — Sr. VP Human Resources Officer
Period of report
Feb 23, 2016
Accepted (ET)
Feb 25, 2016 · 11:42 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2016 | A | 730 | $59.64 | A | 5,277 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $59.64 | Feb 23, 2016 | A | 13,012 | A | Feb 23, 2017 | Feb 23, 2026 | Common Stock | 13,012 | 13,012 | D |
Explanation of responses
- F1Bonus and incentive shares granted on 02/23/2016.